MedPath

Shanghai Changzheng Hospital

🇨🇳China
Ownership
Private
Established
1955-01-01
Employees
-
Market Cap
-
Website
http://www.shczyy.com

A Clinical Trial for the Safety and Efficacy of CD-801 in Patients With Advanced Hepatocellular Carcinoma

Early Phase 1
Completed
Conditions
Advanced Hepatocellular Carcinoma
Interventions
First Posted Date
2023-10-23
Last Posted Date
2025-04-24
Lead Sponsor
Shanghai Changzheng Hospital
Target Recruit Count
2
Registration Number
NCT06092112
Locations
🇨🇳

Changzheng Hospital,Naval Medical University, Shanghai, Shanghai, China

Oral Prednisone in Treating LCH of Bone in Childhood and Adolescence

Phase 2
Recruiting
Conditions
Langerhans Cell Histiocytosis of Bone
Interventions
First Posted Date
2023-10-12
Last Posted Date
2024-02-01
Lead Sponsor
Shanghai Changzheng Hospital
Target Recruit Count
118
Registration Number
NCT06078969
Locations
🇨🇳

Shanghai Changzheng Hospital, Shanghai, Shanghai, China

The Observation on the Efficacy of Dual Therapy Based on Vonoprazan in Eradicating Helicobacter Pylori

Not Applicable
Not yet recruiting
Conditions
The Eradication Rate of Helicobacter Pylori
Interventions
First Posted Date
2023-08-22
Last Posted Date
2023-08-22
Lead Sponsor
Shanghai Changzheng Hospital
Target Recruit Count
400
Registration Number
NCT06004401

A Phase 2 Clinical Trial to Evaluate Zanubrutinib Combined With BR (Bendamustine/Rituximab) Regimen in Subjects With Newly-diagnosed Waldenström's Macroglobulinemia

Phase 2
Recruiting
Conditions
Waldenström's Macroglobulinemia
Interventions
First Posted Date
2023-08-07
Last Posted Date
2023-09-14
Lead Sponsor
Shanghai Changzheng Hospital
Target Recruit Count
60
Registration Number
NCT05979948
Locations
🇨🇳

Shanghai Changzheng Hospital, Shanghai, Shanghai, China

Study of FasT CAR-T GC012F Injection NDMM Patients

Early Phase 1
Recruiting
Conditions
Multiple Myeloma
Interventions
Biological: GC012F injection
First Posted Date
2023-05-03
Last Posted Date
2024-02-13
Lead Sponsor
Shanghai Changzheng Hospital
Target Recruit Count
18
Registration Number
NCT05840107
Locations
🇨🇳

Shanghai Changzheng Hospital, Shanghai, Shanghai, China

Study of CT071 Injection in RRMM or PPCL

Early Phase 1
Active, not recruiting
Conditions
Primary Plasma Cell Leukemia
Multiple Myeloma
First Posted Date
2023-05-01
Last Posted Date
2025-01-07
Lead Sponsor
Shanghai Changzheng Hospital
Target Recruit Count
20
Registration Number
NCT05838131
Locations
🇨🇳

Shanghai Changzheng Hospital, Shanghai, China

Treating Donors With Intravenous Immunoglobulin to Reduce Donor-Derived Infections

Phase 4
Not yet recruiting
Conditions
Viremia
Bacteremia
Acute Rejection of Renal Transplant
Interventions
First Posted Date
2023-04-05
Last Posted Date
2023-04-05
Lead Sponsor
Shanghai Changzheng Hospital
Target Recruit Count
40
Registration Number
NCT05799716

mNGS for Therapy of Urinary Infectious Diseases

Not yet recruiting
Conditions
Sequelae of; Infection
Urinary Tract Infections
Interventions
Diagnostic Test: mNGS of urine cell-free DNA
First Posted Date
2022-11-22
Last Posted Date
2022-11-22
Lead Sponsor
Shanghai Changzheng Hospital
Target Recruit Count
72
Registration Number
NCT05624476

Preoperative Nivolumab Plus Bevacizumab Combined With Chemotherapy Before Surgery in Patients With pMMR/MSS Colorectal Cancer Liver Metastases

Phase 2
Not yet recruiting
Conditions
Colorectal Cancer Liver Metastases
Interventions
Drug: CapOx(Capecitabine+ Oxaliplatin)
First Posted Date
2022-10-20
Last Posted Date
2022-10-20
Lead Sponsor
Shanghai Changzheng Hospital
Target Recruit Count
12
Registration Number
NCT05588297

CapeOX Combined With Bevacizumab Plus Anti-PD1 Antibody as Neoadjuvant Therapy for Microsatellite Stable Locally Advanced Rectal Cancer

Phase 2
Recruiting
Conditions
Locally Advanced Colorectal Cancer
Interventions
First Posted Date
2022-10-19
Last Posted Date
2025-03-14
Lead Sponsor
Shanghai Changzheng Hospital
Target Recruit Count
30
Registration Number
NCT05585814
Locations
🇨🇳

Shanghai Changzheng Hospital, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath